What the current research reveals about utilizing amnion/chorion allografts for diabetic foot ulcers

One-third of diabetic foot ulcers fail standard of care treatment (which involves debridement, offloading, moist wound therapy and bioburden control), and enter a state of chronically impaired healing. Along with abnormally expressed growth factors and cytokines in DFUs, there is impaired extracellular matrix remodeling and deregulation of protease levels that researchers widely believe result in chronic inflammation, a principal factor with delayed healing.

One-third of diabetic foot ulcers fail standard of care treatment (which involves debridement, offloading, moist wound therapy and bioburden control), and enter a state of chronically impaired healing. Along with abnormally expressed growth factors and cytokines in DFUs, there is impaired extracellular matrix remodeling and deregulation of protease levels that researchers widely believe result in chronic inflammation, a principal factor with delayed healing.

Read the original post:
What the current research reveals about utilizing amnion/chorion allografts for diabetic foot ulcers